NDC 52544-039
Kadian
Morphine Sulfate
Kadian is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Morphine Sulfate.
Product ID | 52544-039_15770ad4-855d-46cc-ba48-11556f40a7b6 |
NDC | 52544-039 |
Product Type | Human Prescription Drug |
Proprietary Name | Kadian |
Generic Name | Morphine Sulfate |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2012-05-07 |
Marketing End Date | 2019-05-31 |
Marketing Category | NDA / NDA |
Application Number | NDA020616 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | MORPHINE SULFATE |
Active Ingredient Strength | 40 mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | N |